Overview of Dr. Yaeger
Dr. Rona Yaeger is an oncologist in New York, NY and is affiliated with Memorial Sloan-Kettering Cancer Center. She received her medical degree from NYU School of Medicine and has been in practice 14 years. She specializes in medical oncology.
Office
160 East 53rd Street
New York, NY 10022
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2003 - 2006
- New York University School of MedicineClass of 2003
Certifications & Licensure
- FL State Medical License 2021 - Present
- NY State Medical License 2004 - 2026
- NJ State Medical License 2020 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Vemurafenib and Panitumumab Combination Therapy in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Start of enrollment: 2013 Jan 01
- This Study Aims to Find and Test a Safe Dose of BI 905677 in Patients With Different Types of Cancer (Solid Tumours) Start of enrollment: 2018 Aug 08
Publications & Presentations
PubMed
- Clinicogenomic predictors of survival and intracranial progression after stereotactic radiosurgery for colorectal cancer brain metastases.Chengcheng Gui, Henry S Walch, Kirin D Mueller, Lillian A Boe, A Turan Ilica
Journal of Neurosurgery. 2025-02-01 - Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial.Scott Kopetz, Takayuki Yoshino, Eric Van Cutsem, Cathy Eng, Tae Won Kim
Nature Medicine. 2025-01-25 - Analysis of Shared Variants between Cancer Biospecimens.Michael B Foote, James Robert White, Walid K Chatila, Guillem Argilés, Steve Lu
Clinical Cancer Research. 2025-01-17
Press Mentions
- Two Positive Trials and a Breakthrough Therapy Designation for KRAS InhibitorsDecember 22nd, 2022
- Stress Response Protein Links Inflammatory Disease to Colon CancerFebruary 19th, 2021
- Investigators Test Breakthrough-Designated Triplet in First-Line CRCJanuary 17th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: